Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Van Assche, GA" or (type any "bookEditor journalEditor issueEditor" and editor="Van Assch...

Add to list
- Conference Paper
- C3
Mucosal gene expression profiling differentiates early from late ileal Crohn's disease

I Arijs, L Van Lommel, G De Hertogh, K Machiels, K Lemaire, Kristel Van Steen (UGent) , GA Van Assche, S Vermeire, FC Schuit and PJ Rutgeens

(2011) GASTROENTEROLOGY. 140(5, suppl. 1). p.S270-S270
Add to list
- Conference Paper
- C3
TECK and MADCAM-1 mucosal expression in active IBD : the effect of infliximab therapy

I Arijs, R Quintens, L Van Lommel, Kristel Van Steen (UGent) , G De Hertogh, GA Van Assche, S Vermeire, K Geboes, FC Schuit and PJ Rutgeerts

(2009) GASTROENTEROLOGY. 136(5, suppl. 1). p.A207-A208
Add to list
- Conference Paper
- C3
The impact of infliximab therapy on colonic mucosal expression of barrier genes in patients with inflammatory bowel disease

I Arijs, R Quintens, L Van Lommel, Kristel Van Steen (UGent) , G De Hertogh, GA Van Assche, S Vermeire, K Geboes, FC Schuit and PJ Rutgeerts

(2009) GASTROENTEROLOGY. 136(5, suppl. 1). p.A210-A210
Add to list
- Conference Paper
- C3
Predictive value of C-reactive protein level changes on the long term outcome of infliximab in Crohn's disease

M Jurgens, F Schnitzler, Kristel Van Steen (UGent) , J Mahachie, V Ballet, M Noman, I Hoffman, GA Van Assche, PJ Rutgeerts and S Venneire

(2009) GASTROENTEROLOGY. 136(5, suppl. 1). p.A171-A171
Add to list
- Conference Paper
- C3
Mucosal gene signatures to predict response to infliximab in patients with inflammatory bowel disease

I Arijs, L Van Lommel, Kristel Van Steen (UGent) , G De Hertogh, M Ferrante, Marie Joossens (UGent) , K Geboes, GA Van Assche, S Vermeire, FC Schuit, et al.

(2008) GASTROENTEROLOGY. 134(4, suppl. 1). p.A117-A117
Add to list
- Conference Paper
- C3
Mucosal healing predicts sustained clinical remission in early Crohn's disease

FJ BAERT, L MOORTGAT, GA VAN ASSCHE, P CAENEPEEL, PL VERGAUWE, Martine De Vos (UGent) , PC STOKKERS, DW HOMMES, S VERMEIRE, PJ RUTGEERTS, et al.

(2008) GASTROENTEROLOGY. 134(4).
Add to list
- Conference Paper
- C3
Microarray study of mucosal antimicrobial peptides in patients with inflammatory bowel disease before and after first infliximab treatment

I Arijs, L Van Lommel, Kristel Van Steen (UGent) , G De Hertogh, R Quintens, K Lemaire, Marie Joossens (UGent) , FC Schuit, K Geboes, GA Van Assche, et al.

(2008) GASTROENTEROLOGY. 134(4, suppl. 1). p.A457-A457

Academic Bibliography

Mucosal gene expression profiling differentiates early from late ileal Crohn's disease

TECK and MADCAM-1 mucosal expression in active IBD : the effect of infliximab therapy

The impact of infliximab therapy on colonic mucosal expression of barrier genes in patients with inflammatory bowel disease

Predictive value of C-reactive protein level changes on the long term outcome of infliximab in Crohn's disease

Mucosal gene signatures to predict response to infliximab in patients with inflammatory bowel disease

Mucosal healing predicts sustained clinical remission in early Crohn's disease

Microarray study of mucosal antimicrobial peptides in patients with inflammatory bowel disease before and after first infliximab treatment

Contents

Support

Contact